Skip to content

Clinical trials

Completed Mental Disorders trials in Russia

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Mental Disorders Status: Completed Country / region: Russia Clear all

15 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20081
20091
20102
20113
20122
20132
20142
20201
20241

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed15

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Otsuka Pharmaceutical Development & Commercialization, Inc.6
Forest Laboratories2
Pfizer2
H. Lundbeck A/S1
Pierre Fabre Medicament1
S.LAB (SOLOWAYS)1
Semmelweis University1
Takeda1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Mental Disorders15
Depressive Disorder4
Major Depressive Disorder4
Mood Disorders4
Alzheimer Disease3
Cognitive Dysfunction3
Dementia3
Nervous System Diseases3
Psychomotor Agitation3
Schizophrenia3

Trials

Showing 1 to 15 of 15. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.